Abstract
Myleodysplastic syndromes (MDS) are pre-malignant hematopoietic diseases that can progress to acute myeloid leukemia (AML) progression in conjunction with changes in immune function. In this model of leukemia evolution, the expansion of immunosuppressive regulatory T cells (Tregs) contributes to immune escape. Here, we discuss the importance of Tregmemory phenotype switching as a poor prognostic indicator in MDS. © 2013 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
Adam, W. M., & Epling-Burnette, P. K. (2013, February). Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes. OncoImmunology. https://doi.org/10.4161/onci.22654
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.